Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity

BACKGROUND: Premature neonates are at risk for severe anemia and erythropoietin is the most important hormone in erythropoiesis. The aim of this study was to evaluate the influence of oral recombinant human erythropoietin (rhEPO) in proving erythropoiesis in neonates. METHODS: This was a randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeidi, R, Banihashem, A, Hammoud, M, Gholami, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372031/
https://www.ncbi.nlm.nih.gov/pubmed/22737576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372031/
https://www.ncbi.nlm.nih.gov/pubmed/22737576

Ejemplares similares